Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Rachel Studer"'
Publikováno v:
BMC Cardiovascular Disorders, Vol 22, Iss 1, Pp 1-11 (2022)
Abstract Background Heart failure (HF) is a global illness and is a leading cause of hospitalizations. Recurrent HF hospitalization (HFH) is associated with increased risk of cardiovascular (CV) and all-cause mortality, thereby burdening the health s
Externí odkaz:
https://doaj.org/article/601964b56dd641d2a19b9089e0c9e672
Autor:
Panagiotis Orfanos, Ana Filipa Fonseca, Xingdi Hu, Raju Gautam, Glenn Montgomery, Rachel Studer, Japinder Kaur, Nehul Saxena, Nitin Kaushik
Publikováno v:
PLoS ONE, Vol 18, Iss 11 (2023)
Externí odkaz:
https://doaj.org/article/ee8217f695db4300a40f301982927af9
Autor:
Krister Lindmark, Kurt Boman, Jan Stålhammar, Mona Olofsson, Raquel Lahoz, Rachel Studer, Clare Proudfoot, Stefano Corda, Ana Filipa Fonseca, Madlaina Costa‐Scharplatz, Aaron Levine, Michael Törnblom, Anna Castelo‐Branco, Eleni Kopsida, Gerhard Wikström
Publikováno v:
ESC Heart Failure, Vol 8, Iss 3, Pp 2144-2153 (2021)
Abstract Aims Heart failure (HF) is a leading cause of hospitalization and is associated with high morbidity and mortality. We examined the impact of recurrent HF hospitalizations (HFHs) on cardiovascular (CV) mortality among patients with HF in Swed
Externí odkaz:
https://doaj.org/article/46c1101e17ae41c6b42b57eb9a4a79d7
Autor:
Jenni Huusko, Samuli Tuominen, Rachel Studer, Stefano Corda, Clare Proudfoot, Mariann Lassenius, Heikki Ukkonen
Publikováno v:
ESC Heart Failure, Vol 7, Iss 5, Pp 2406-2417 (2020)
Abstract Aims The proportion of patients hospitalized for heart failure (HF) with preserved left ventricular ejection fraction (LVEF) is rising, but no approved treatment exists, in part owing to incomplete characterization of this particular HF phen
Externí odkaz:
https://doaj.org/article/e3342b29820f465bbfaa932c71077c37
Publikováno v:
ESC Heart Failure, Vol 7, Iss 4, Pp 1688-1699 (2020)
Abstract Aims Heart failure (HF) is a leading cause of hospitalization and is associated with high morbidity and mortality post‐diagnosis. Here, we examined the impact of recurrent HF hospitalization (HFH) on cardiovascular (CV) and all‐cause mor
Externí odkaz:
https://doaj.org/article/78bcd34c20bc42ec8668108408f2ce68
Autor:
Mufaddal Mahesri, Kristyn Chin, Abheenava Kumar, Aditya Barve, Rachel Studer, Raquel Lahoz, Rishi J Desai
Publikováno v:
PLoS ONE, Vol 16, Iss 6, p e0252903 (2021)
BackgroundEjection fraction (EF) is an important prognostic factor in heart failure (HF), but administrative claims databases lack information on EF. We previously developed a model to predict EF class from Medicare claims. Here, we evaluated the per
Externí odkaz:
https://doaj.org/article/937e1ffa85004b9e9322b447c29ed62d
Autor:
Ana F Fonseca, Hannah Byrne, Andres Laguna, Taha Itani, Rachel Studer, Jihaeng Heo, Allison Dillon, Philippe Ferber, Madlaina Costa-Scharplatz
Publikováno v:
Journal of Managed Care & Specialty Pharmacy. 29:519-529
Autor:
Emma Houchen, Emil Loefroth, Raymond Schlienger, Clare Proudfoot, Stefano Corda, Sibasish Saha, Sarvesh K. Satwase, Rachel Studer
Publikováno v:
Cardiology and Therapy
Introduction The angiotensin receptor neprilysin inhibitor (ARNI) sacubitril/valsartan (SAC/VAL) has shown benefit in patients with symptomatic heart failure (HF), including those naïve to renin–angiotensin–aldosterone system inhibitor (RAASi) t
Autor:
Aaron Levine, Clare Proudfoot, Kurt Boman, Madlaina Costa-Scharplatz, Jan Stålhammar, Gerhard Wikström, Anna Castelo-Branco, A.F Fonseca, Rachel Studer, Krister Lindmark, M. Tornblom, S Corda, Raquel Lahoz, Mona Olofsson, Eleni Kopsida
Publikováno v:
ESC Heart Failure
ESC Heart Failure, Vol 8, Iss 3, Pp 2144-2153 (2021)
ESC Heart Failure, Vol 8, Iss 3, Pp 2144-2153 (2021)
Aims Heart failure (HF) is a leading cause of hospitalization and is associated with high morbidity and mortality. We examined the impact of recurrent HF hospitalizations (HFHs) on cardiovascular (CV) mortality among patients with HF in Sweden. Metho
Publikováno v:
ESC Heart Failure, Vol 7, Iss 4, Pp 1688-1699 (2020)
ESC Heart Failure
ESC Heart Failure
Aims Heart failure (HF) is a leading cause of hospitalization and is associated with high morbidity and mortality post‐diagnosis. Here, we examined the impact of recurrent HF hospitalization (HFH) on cardiovascular (CV) and all‐cause mortality am